Teva raises its stake in acquisition target Mylan

(Reuters) - Teva Pharmaceutical Industries Ltdhas increased its stake in Mylan NVto nearly 2.2 percent as it presses on with an unsolicited bid for its generic drug-making rival, a regulatory...